GGrantIndex
Sort

64,565 grants matching drug discovery

Protein Microcharacterization

$1,091,797
Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2017 · ES

Vaccine Discovery for Chagas Disease

$1,091,483
University Of Georgia (Uga) · P01 · FY2005 · AI

Center for Cancer Experimental Therapeutics

$1,091,476
Barbara Timmermann · University Of Kansas Lawrence · P30 · FY2011 · RR

Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways

$1,091,444
Matthew D Disney · Scripps Florida · P01 · FY2020 · NS

Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

$1,091,431
Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2021 · AG

SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS

$1,091,364
Duke University · P50 · FY2002 · NS

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,090,698
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Design And Development Of Experimental Therapeutics

$1,090,483
Nigel H. Greig · National Institute On Aging · ZIA · FY2018 · AG

Aging, Oxidative Stress and Cell Death

$1,090,348
Brian A. Herman · University Of Texas Hlth Science Center · P01 · FY2010 · AG

Inhibition Of Renal Injury

$1,090,302
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

A Haplotype Map for Multiple Sclerosis

$1,089,455
Stephen L Hauser · University Of California, San Francisco · R01 · FY2010 · NS

CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE

$1,089,205
Shafiq A Khan · Clark Atlanta University · P20 · FY2015 · MD

Preclinical Development of HIV-1 Vif Antagonists

$1,089,177
Mario Stevenson · University Of Miami School Of Medicine · U19 · FY2012 · MH

HIV Assay Development and Testing to Identify Targeted Activator of Cell Kill Molecules

$1,088,954
Rangan Maitra · Research Triangle Institute · N01 · FY2025 · AI

Long-lasting cocaine-metabolizing enzyme for cocaine addiction treatment

$1,088,896
Chang-Guo Zhan · University Of Kentucky · R01 · FY2015 · DA

An integrated computational and functional genomics discovery engine for preclini

$1,088,820
Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA

RaceCAR-M immunotherapy for cancer and beyond

$1,088,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2025 · CA

RaceCAR-M immunotherapy for cancer and beyond

$1,088,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2024 · CA

Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy

$1,088,500
Gerald W. Dorn · Washington University · R35 · FY2024 · HL

DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study

$1,088,316
Douglas Postels · Children'S Research Institute · U01 · FY2021 · AI

Center of Excellence for High Throughput Proteogenomic Characterization

$1,088,100
Steven A. Carr · Broad Institute, Inc. · U24 · FY2022 · CA

Kansas PKD Research and Translation Core Center

$1,088,089
James P Calvet · University Of Kansas Medical Center · P30 · FY2015 · DK

Center of Excellence for High Throughput Proteogenomic Characterization

$1,088,025
Steven A. Carr · Broad Institute, Inc. · U24 · FY2025 · CA

Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases

$1,088,000
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

Animal Models as Surrogates, SBIR Phase I ^ RFP No. PHS 2010-1 Topic #13

$1,087,851
Charles Magness · Kineta, Inc. · N01 · FY2011 · HL